A Phase II Study of XELOX and Cetuximab as First-Line Therapy in Patients With KRAS Wild Type Metastatic Colorectal Cancer (FLEET2 Study).

Details

Language :

English

ISSN :

15330028

Volume :

15

Issue :

4

Database :

Complementary Index

Journal :

Clinical Colorectal Cancer

Publication Type :

Academic Journal

Accession number :

120347158

Full Text :

https://doi.org/10.1016/j.clcc.2016.07.003